检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]北京首都医科大学附属北京友谊医院肝病中心,100050 [2]山东滕州滕州市中心人民医院消化内科,277500
出 处:《中国综合临床》2003年第3期243-244,共2页Clinical Medicine of China
摘 要:目的观察腹水超滤浓缩腹腔回输治疗肝硬变顽固性腹水的疗效与安全性。方法采用WLFHY 50 0型伟力电脑腹水超滤浓缩回输系统 ,对 2 3例肝硬变顽固性腹水患者行 2 9例次治疗 ,观察患者体重、腹围、2 4小时尿量及尿钠排出量、血肌酐、尿素氮、电解质、白蛋白等变化 ,随访 3个月以上 ,对疗效进行判定。结果经治疗后 ,患者 2 4小时尿量及尿钠增加 ,血清白蛋白水平增加 ;尿素氮、肌酐、电解质水平无显著性变化 ,总有效率达 6 5.5% ,无严重并发症。结论腹水超滤浓缩腹腔回输治疗肝硬变顽固性腹水 ,方法简便易行 ,且安全有效。Objective To observe the efficacy and safety of ultrafiltration and peritoneal reinfusion of ascites to treat refractory cirrhotic ascites. Methods 23 cirrhotic patients with refractory ascites were treated for 29 times with WLFHY 500 ultrafiltration and peritoneal reinfusin system.The body weight, abdomen circumference, urine volume and urinary natrium output in 24 hours, serum levels of blood urea nitrogen, creatinine, albumin, kalium, natrium and chlorine ions were observed and compared before and after treatment.All patients were followed up for more than 3 months to determine the efficacy. Results After the treatment with ultrafiltration and peritoneal reinfusion of ascites, urine volume and urinary natrium output in 24 hours were elevated and serum albumin was elevated(P<0.01). The serum levels of blood urea nitrogen, creatinine, kalium, natrium and chlorine ions were not significantly changed(P>0.05). The overall efficacy rate was 65.5%. No severe complication occurred. Conclusion Ultrafiltration of ascites and peritoneal reinfusion of ascites is safe and simple to operate with effect.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.66